XIENCE 28 Global Study

Clinical trial NCT03355742 · COMPLETED

Trial details

NCT number: NCT03355742
Sponsor: Abbott Medical Devices
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Bleeding Disorder Stroke, Ischemic Stroke Hemorrhagic Hematological Disease Thrombocytopenia Coagulation Disorder Anemia Renal Insufficiency Coronary Artery Disease

Start date: 2018-02-09
Primary completion: 2019-10-24
Enrollment: 963

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.